RU2120797C1 - Новые композиции в форме подкожных имплантатов на основе производных нормегестрола, способ их получения и применения - Google Patents

Новые композиции в форме подкожных имплантатов на основе производных нормегестрола, способ их получения и применения Download PDF

Info

Publication number
RU2120797C1
RU2120797C1 RU94026906A RU94026906A RU2120797C1 RU 2120797 C1 RU2120797 C1 RU 2120797C1 RU 94026906 A RU94026906 A RU 94026906A RU 94026906 A RU94026906 A RU 94026906A RU 2120797 C1 RU2120797 C1 RU 2120797C1
Authority
RU
Russia
Prior art keywords
implant
methyl
composition according
diene
norpregna
Prior art date
Application number
RU94026906A
Other languages
English (en)
Russian (ru)
Other versions
RU94026906A (ru
Inventor
Ланкетен Мишель
Луи Тома Жан
Пари Жак
Кутино Эльсимар
Original Assignee
Лаборатуар Терамекс С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Терамекс С.А. filed Critical Лаборатуар Терамекс С.А.
Publication of RU94026906A publication Critical patent/RU94026906A/ru
Application granted granted Critical
Publication of RU2120797C1 publication Critical patent/RU2120797C1/ru

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steroid Compounds (AREA)
RU94026906A 1992-09-21 1993-09-17 Новые композиции в форме подкожных имплантатов на основе производных нормегестрола, способ их получения и применения RU2120797C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
FR92/11422 1992-09-21
PCT/FR1993/000900 WO1994006437A1 (fr) 1992-09-21 1993-09-17 Implants sous-cutanes a base de derives de nomegestrol

Publications (2)

Publication Number Publication Date
RU94026906A RU94026906A (ru) 1996-03-27
RU2120797C1 true RU2120797C1 (ru) 1998-10-27

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94026906A RU2120797C1 (ru) 1992-09-21 1993-09-17 Новые композиции в форме подкожных имплантатов на основе производных нормегестрола, способ их получения и применения

Country Status (31)

Country Link
US (1) US5565443A (US06534493-20030318-C00130.png)
EP (1) EP0613372B1 (US06534493-20030318-C00130.png)
JP (1) JPH08506318A (US06534493-20030318-C00130.png)
KR (1) KR100255700B1 (US06534493-20030318-C00130.png)
CN (1) CN1095667C (US06534493-20030318-C00130.png)
AP (1) AP497A (US06534493-20030318-C00130.png)
AT (1) ATE198275T1 (US06534493-20030318-C00130.png)
AU (1) AU683423B2 (US06534493-20030318-C00130.png)
BG (1) BG62317B1 (US06534493-20030318-C00130.png)
BR (1) BR9305642A (US06534493-20030318-C00130.png)
CA (1) CA2122827A1 (US06534493-20030318-C00130.png)
CZ (1) CZ284806B6 (US06534493-20030318-C00130.png)
DE (1) DE69329790D1 (US06534493-20030318-C00130.png)
DZ (1) DZ1717A1 (US06534493-20030318-C00130.png)
EC (1) ECSP930986A (US06534493-20030318-C00130.png)
FI (1) FI942272A (US06534493-20030318-C00130.png)
FR (1) FR2695826B1 (US06534493-20030318-C00130.png)
HU (1) HUT67044A (US06534493-20030318-C00130.png)
IL (1) IL107039A (US06534493-20030318-C00130.png)
MA (1) MA22978A1 (US06534493-20030318-C00130.png)
NO (1) NO306238B1 (US06534493-20030318-C00130.png)
OA (1) OA09924A (US06534493-20030318-C00130.png)
PL (1) PL176120B1 (US06534493-20030318-C00130.png)
RO (1) RO115783B1 (US06534493-20030318-C00130.png)
RU (1) RU2120797C1 (US06534493-20030318-C00130.png)
SK (1) SK54694A3 (US06534493-20030318-C00130.png)
TN (1) TNSN93104A1 (US06534493-20030318-C00130.png)
TW (1) TW381024B (US06534493-20030318-C00130.png)
WO (1) WO1994006437A1 (US06534493-20030318-C00130.png)
YU (1) YU60493A (US06534493-20030318-C00130.png)
ZA (1) ZA936964B (US06534493-20030318-C00130.png)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
BR0210722A (pt) 2001-06-29 2004-07-20 Medgraft Microtech Inc Implantes injetáveis biodegradáveis e métodos relacionados de produção e uso
US7736665B2 (en) * 2002-05-31 2010-06-15 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine
KR101152183B1 (ko) 2003-03-31 2012-06-15 타이탄 파머슈티컬즈 인코퍼레이티드 도파민 아고니스트의 지속 방출을 위한 이식가능한 폴리머디바이스
JP2007502866A (ja) * 2003-05-30 2007-02-15 タイタン ファーマシューティカルズ インコーポレイテッド ナルメフェンの持続的放出のための移植可能ポリマー装置
MXPA06003316A (es) 2003-10-10 2006-06-08 Antares Pharma Ipl Ag Formulacion farmaceutica transdermica para minimizar los residuos en la piel.
CA2575988C (en) 2004-08-04 2014-02-18 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FR, патент 2236508 (Sosiete dite Akzo N.V.) 14.03.1975, A 61 K 31/575. *

Also Published As

Publication number Publication date
OA09924A (fr) 1994-09-15
NO306238B1 (no) 1999-10-11
AU4822993A (en) 1994-04-12
SK54694A3 (en) 1994-10-05
ZA936964B (en) 1994-04-14
CN1095667C (zh) 2002-12-11
US5565443A (en) 1996-10-15
BG62317B1 (bg) 1999-08-31
FR2695826A1 (fr) 1994-03-25
IL107039A0 (en) 1993-12-28
AU683423B2 (en) 1997-11-13
EP0613372B1 (fr) 2000-12-27
RO115783B1 (ro) 2000-06-30
AP497A (en) 1996-05-28
CN1094284A (zh) 1994-11-02
CZ284806B6 (cs) 1999-03-17
AP9300576A0 (US06534493-20030318-C00130.png) 1993-10-31
HUT67044A (en) 1995-01-30
CA2122827A1 (fr) 1994-03-31
NO941900D0 (no) 1994-05-20
MA22978A1 (fr) 1994-04-01
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
ATE198275T1 (de) 2001-01-15
HU9401395D0 (en) 1994-08-29
FI942272A0 (fi) 1994-05-16
PL176120B1 (pl) 1999-04-30
ECSP930986A (es) 1994-04-12
YU60493A (sh) 1997-01-08
FI942272A (fi) 1994-05-16
WO1994006437A1 (fr) 1994-03-31
TNSN93104A1 (fr) 1994-03-17
EP0613372A1 (fr) 1994-09-07
DZ1717A1 (fr) 2002-02-17
FR2695826B1 (fr) 1995-01-06
CZ116494A3 (en) 1995-03-15
TW381024B (en) 2000-02-01
IL107039A (en) 1999-01-26
DE69329790D1 (de) 2001-02-01
BG98776A (bg) 1995-02-28
KR100255700B1 (ko) 2000-08-01
BR9305642A (pt) 1996-01-09

Similar Documents

Publication Publication Date Title
RU2120797C1 (ru) Новые композиции в форме подкожных имплантатов на основе производных нормегестрола, способ их получения и применения
DK2905014T3 (en) An intrauterine delivery system for contraception
CA2243274C (en) Male contraceptive implant
CN100594907C (zh) 由雌二醇和胆固醇组成的稳定形状颗粒的制备方法
IL149663A (en) Devices for the administration of drugs with antiprogastinal properties
EA018112B1 (ru) Вагинальная система доставки
JP2001524124A (ja) テストステロンおよびテストステロン前駆体の投与のための膣内薬物送達用具
HU223690B1 (hu) Szilikonmaggal rendelkező hosszan tartóan androgént adagoló implantátum
Sam Controlled release contraceptive devices: a status report
AU747710B2 (en) Progestogen-antiprogestogen regimens
EP2062569B1 (en) Vaginal delivery system
EP0081370A1 (en) Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles
Singh et al. Biodegradable norethindrone (NET: cholesterol) contraceptive implants: Phase II-A: A clinical study in women
Sondheimer Cervical mucus and contraception
Roy Current status of NORPLANT subdermal implants for contraception